Metabolomics data
Targeted metabolomics data from blood samples using five different platforms (amines, acylcarnitines, organic acids, signaling lipids and lididomics)
LHA ID: 8TGUE045VV-3
Experimental assay
Projects: Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD)
Investigation: Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD) WP 1
Study: SysMedPD metabolomics study
Assay position:
Resource type: Metabolite Profiling
Technology type: Mass Spectrometry
Human Diseases: Parkinson's disease
Export PNG
Download
Creators and Submitter
Views: 74
Created: 30th Dec 2024 at 14:45
Last updated: 30th Dec 2024 at 15:03
TagsThis item has not yet been tagged.
Related items
The Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD) study was initiated by an international consortium to contribute to the elucidation of mitochondrial underpinnings of Parkinson's Disease (PD).
Programme: This Project is not associated with a Programme
Public web page: http://www.sysmedpd.eu
Submitter: Silke Szymczak
Studies: SysMedPD metabolomics study
Resources: Clinical data, Data access, Metabolomics data
Recruitment of patients with idiopathic and different forms of monogenic PD, as well as healthy controls, took place at the Institute of Neurogenetics at the University of Lübeck (UL) and the Department of Neurology at the University College London (UCL). Large-scale blood based targeted metabolomics analyses of 304 metabolites covering acylcarnitines, amines, organic acids, lipids and signaling lipids were performed in 140 idiopathic and 19 monogenic PD patients and 64 controls.
Submitter: Silke Szymczak
Investigation: Systems Medicine of Mitochondrial Parkinson’s D...
Resources: Clinical data, Data access, Metabolomics data
Study type: Case control study
https://orcid.org/0000-0002-8897-9035
Taxonomy URI: http://purl.obolibrary.org/obo/DOID_14330
Synonyms: Parkinson disease, paralysis agitans
Definitions: A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions., Xref MGI. OMIM mapping confirmed by DO. [SN].
